Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank33
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-7.99M
↓ 16% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-6.87M
Historical baseline
PeriodValueYoY Change
TTM$-7.99M-129.6%
2024$26.98M+257.4%
2023$-17.14M+5.1%
2022$-18.06M-27.0%
2021$-14.22M+8.8%
2020$-15.60M-72.1%
2019$-9.06M-15.8%
2018$-7.83M-114.9%
2017$-3.64M-71.4%
2016$-2.12M-